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Abstract 
Background: Exposures to environmental phenols and parabens may be harmful, especially in 
utero. Prior studies have demonstrated high within-person variability of urinary concentrations 
across pregnancy.  
Objectives: We sought to measure phenol and paraben biomarker concentrations for the 
Norwegian Mother and Child Cohort (MoBa) study, assess within-person variability, and 
investigate any possible external phenol or paraben contamination of specimens. 
Methods: We collected three spot urines at approximately 17, 23, and 29 weeks’ gestation in a 
hospital setting and added a preservative containing ethyl paraben. We measured urinary 
concentrations and within-person variability for phenols and parabens in a MoBa sample (n=45), 
including a subgroup of 15 participants previously randomly selected for a bisphenol-A (BPA) 
exposure study who had unusually high total BPA concentrations. Additionally, we compared 
reliability results for total, conjugated, and free concentrations of phenolic compounds.  
Results: We detected total and free BPA, butyl paraben, propyl paraben, and methyl paraben in 
100% of samples, total benzophenone-3 in 95% of samples, and infrequently detected free 
benzophenone-3 and total and free 2,4-dichlorophenol and 2,5-dichlorophenol. Intraclass 
correlation coefficients (ICCs) for total, conjugated, and free concentrations ranged from 
relatively low for BPA to moderate for propyl paraben. ICCs were generally similar overall and 
by subgroup.  
Conclusions: Using conjugated concentrations improved reliability estimates only for BPA. 
Measuring total and free concentrations, an approach which may be useful for future studies, 
allowed us to identify likely BPA and butyl paraben contamination of archived MoBa urine 
specimens.  
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Introduction 
Phenols, including bisphenol A (BPA) and benzophenone-3, and parabens, which also contain a 
phenolic ring, are found in a number of common consumer products (Centers for Disease 
Control and Prevention (CDC) 2009; CDC 2010). The ubiquity of human exposure to phenolic 
compounds has sparked questions regarding toxicity, especially from exposures during sensitive 
periods, e.g., in utero (Bushnik et al. 2010; Calafat et al. 2008; Calafat et al. 2010; Mahalingaiah 
et al. 2008; Vandenberg et al. 2010; Wolff et al. 2008; Woodruff et al. 2011). Prenatal exposures 
to phenols have been associated with decreased gestational age at birth (BPA and benzophenone-
3) (Tang et al. 2013), decreased birth weight (2,4-dichlorophenol and 2,5-dichlorophenol) 
(Philippat et al. 2013; Wolff et al. 2008), and child behavior problems, with some evidence of 
sex differences (BPA) (Braun et al. 2009; Braun et al. 2011b; Harley et al. 2013; Perera et al. 
2012). Concentrations of phenol and paraben biomarkers in spot urine samples, which provide 
exposure measurements at one point in time, are frequently used to estimate recent exposures. 
However, many phenolic compounds are rapidly excreted (Volkel et al. 2002), and the degree to 
which a single measure can be used to represent longer-term or cumulative exposure in part 
depends on population-specific factors such as geographic location, demographic characteristics, 
and lifestyle (Koch et al. 2014; Meeker et al. 2013; Ye et al. 2009). 
Phenolic compounds in humans can be metabolized via conjugation (Environmental Protection 
Agency (EPA) 2002; Matthews et al. 2001); these conjugated species are readily excreted via 
urine (Volkel et al. 2002). Generally, conjugated phenolic compounds comprise the bulk (≥90%) 
of the total biomarker concentration in urine (EPA 2002; Koch et al. 2012; Liao and Kannan 
2012; Volkel et al. 2002; Ye et al. 2005b). The remainder of the total urinary phenolic biomarker 
concentration consists of unconjugated (free) species that can arise from several sources: (1) free 
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phenolic compounds that passed through the body without conjugation, representing a 
biologically active form (EPA 2002; Koch et al. 2012; Volkel et al. 2002); (2) free phenolic 
compounds that entered the sample via contamination during collection or processing (EPA 
2002; Koch et al. 2012; Volkel et al. 2002); (3) conjugated phenolic compounds hydrolyzed to 
the free form by enzymes in local tissues (Waechter et al. 2007); or (4) conjugated phenolic 
compounds hydrolyzed to the free form following improper storage or handling (Ye et al. 2007).   
In field studies, exposure assessment is complicated by the ubiquitous presence of phenolic 
compounds in the environment. This has implications for population exposure levels as well as 
protocols for sample collection, processing, and analysis, which must be designed to minimize 
the potential for external sample contamination (Calafat and Needham 2009). For example, the 
use of BPA in laboratory supplies necessitates fastidious handling to ensure sample integrity (Ye 
et al. 2013). Both collection conditions and preservatives to prevent bacterial growth in urine can 
contribute to contamination of urine samples with BPA (Longnecker et al. 2013). Similarly, 
personal care products used by laboratory technicians that contain benzophenone-3 and parabens 
have contaminated biological samples (Ye et al. 2013).  
Accurate exposure assessment is critical to establishing reliable estimates of associations 
between background phenolic exposures and health outcomes. Exposures to select phenols 
(Meeker et al. 2013; Woodruff et al. 2011; Ye et al. 2009) and the reliability of a single spot 
urine to estimate exposure to phenolic compounds over the course of pregnancy can vary 
substantially across populations (Braun et al. 2011a; Braun et al. 2012; Jusko et al. 2014; Meeker 
et al. 2013; Philippat et al. 2013; Quiros-Alcala et al. 2013). These findings suggest that 
reliability estimates for these compounds may not be generalizable across populations, 
particularly when patterns of product usage or population exposures may be different. 
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The purpose of our study was threefold. First, we wanted to measure the concentrations of 
phenols and parabens in archived urine collected from women in the Norwegian Mother and 
Child cohort (MoBa). Second, we sought to characterize the reliability of a single spot urine 
sample to estimate environmental exposure to these compounds over the course of pregnancy in 
the MoBa cohort. Third, given the recently reported potential for contamination of MoBa 
specimens (Longnecker et al. 2013), we investigated whether using the free and conjugated 
concentrations of phenolic biomarkers might improve reliability estimates.  
Methods 
Study design 
MoBa is a prospective population-based pregnancy cohort conducted by the Norwegian Institute 
of Public Health (Magnus et al. 2006). MoBa was initiated for the study of exposures and 
diseases related to pregnancy and child development, including potential health effects 
associated with exposures to environmental chemicals (Magnus et al. 2006). From 1999-2008, 
pregnant women across Norway were recruited at their first ultrasound visit (approximately 17-
18 weeks’ gestation) and 38.5% of invited women consented to participate. The final cohort 
includes 90,700 mothers and 108,000 pregnancies (Norwegian Institute of Public Health 2013).  
Beginning in 2002, as part of the standard data collection protocol, MoBa participants provided a 
spot urine specimen in a collection cup at the ultrasound visit. Due to evidence of bacterial 
growth upon receipt at the central processing facility, MoBa revised the protocol to include the 
addition of a preservative to urine specimens. Laboratory staff transferred 8 mL of urine from 
each specimen to a Vacutainer tube (Urinalysis Preservative Plus Urine Tube, BD Diagnostics) 
with a mixture of three preservatives (sodium propionate 94%, ethyl paraben 5.6%, and 
chlorhexidine 0.4%) and shipped the specimen, unrefrigerated, to a central processing facility 
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(Ronningen et al. 2006; Hoppin et al. 2006). At the processing facility, urine samples were 
partitioned into 930 µl aliquots and stored at -80 ºC until use (Ronningen et al. 2006). 
From November 2007 to December 2008, a subset of MoBa participants (n=671) donated a spot 
urine at approximately 17 weeks of gestation plus additional urine specimens at approximately 
23 and 29 weeks of gestation for a reliability substudy. These participants were recruited from 
hospitals representing four regions of Norway [northwest (Sunnmøre Hospital HF Ålesund), 
southwest (Stavanger University Hospital HF), central (St Olavs Hospital HF), and east (Østfold 
Hospital HF Fredrikstad)] and specimens were collected using the protocol described above.  
From the subset of 671, we randomly selected 30 participants for this reliability substudy. 
Another 15 participants from the same subset of 671 that were part of a previous random 
selection for an unpublished pilot study were also included. The pilot study showed that these 15 
women had the highest measured total BPA concentrations (range of 22.9-52.1 micrograms per 
gram of creatinine); we included them to determine if the high concentrations could possibly be 
attributed to contamination. The final study sample thus included 135 urine samples from 45 
women. 
For quality control (QC), in 2011 we collected spot urine specimens from 10 Norwegian women 
using the same collection protocol and materials used for MoBa participants, except that the 
specimens did not require shipping because they were collected from processing facility staff. 
QC samples were pooled before transfer to the tube c preservative and aliquotted prior to 
analysis.  
Informed consent was obtained from each MoBa participant upon recruitment. The MoBa study 
was approved by The Regional Committee for Medical Research Ethics in South-Eastern 
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Norway (#2011/1386). The reliability substudy was also approved by The Regional Committee 
for Medical Research Ethics in South-Eastern Norway and the University of North Carolina 
Institutional Review Board. The involvement of the Centers for Disease Control and Prevention 
(CDC) laboratory did not constitute engagement in human subjects research. 
Measurement of phenol and paraben concentrations 
In 2012, we analyzed urine specimens for free and total (conjugated plus free) concentrations of 
nine compounds: BPA, butyl paraben, ethyl paraben, methyl paraben, propyl paraben, 
benzophenone-3, triclosan, 2,4-dichlorophenol, and 2,5-dichlorophenol. Triclosan results are 
presented elsewhere (Bertelsen et al. 2014). Analyses were conducted using online solid phase 
extraction-isotope dilution-high performance liquid chromatography-tandem mass spectrometry 
(online SPE-HPLC-Isotope dilution-MS/MS) (Ye et al. 2005a; Ye et al. 2008) at the CDC 
(Atlanta, USA) in three analytical batches. All urine specimens from a participant were analyzed 
in the same analytical batch in random order. The pooled urine for QC was distributed into 15 
aliquots, and we included five aliquots in each of the three analytical batches. Phenol and 
paraben concentrations are reported in micrograms per liter (µg/L) and micrograms per gram of 
creatinine (µg/g creatinine) to account for urine dilution.  
Statistical analyses 
All statistical analyses were conducted separately for the complete sample (n = 45 participants, 
135 samples, hereafter “Complete Sample”) as well as for the two subgroups: randomly selected 
participants with no previously measured BPA concentrations (n = 30 participants, 90 samples, 
hereafter “Random Sample”) and participants with high total BPA concentrations in a previous 
random selection (n = 15 participants, 45 samples, hereafter “High-BPA Subgroup”). 
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We summarized characteristics of the study population using data from version 7 of the quality-
assured MoBa data files released for research in June 2012. We also computed coefficients of 
variation (CVs) for all QC specimens and between the three QC batches. Between-batch CVs 
based on the QC samples were generally low (<15%) except when mean concentrations were 
near the limit of detection (LOD) (see Supplemental Material, Table S1). 
For the study sample, we calculated conjugated concentrations as the difference between total 
and free concentrations, when both total and free concentrations were detectable. Negative 
conjugated values occurred when free concentrations exceeded total concentrations at levels 
close to the LOD, which are subject to higher measurement error. We computed geometric 
means for total, free and conjugated concentrations with all time periods combined as well as for 
each of the three time points. We used the instrumental values for total phenol and paraben 
concentrations below the LOD; for free phenol and paraben concentrations, instrumental values 
below the LOD were not provided (i.e., missing) because the majority of free concentrations 
were so low that the instrument software recorded them as ”no peak”  or “<0”. We only analyzed 
data for compounds with >50% detection frequency; analytes fulfilling this criterion all had 95-
100% detection frequency, so we did not employ any additional correction (e.g., imputation) for 
these values. To examine potential contamination of specimens, we also compared the 
distributions of free phenol and paraben concentrations as a percent of the total concentration for 
the five compounds with sufficient detection: BPA, butyl paraben, methyl paraben, propyl 
paraben, and benzophenone-3. 
We assessed the proportion of variance attributed to between-person variability across the three 
time points in pregnancy using intra-class correlation coefficients (ICCs). ICCs typically range 
from 0-1 with a value close to 1 indicating high temporal reliability of measurements, with most 
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of the variance due to differences between subjects rather than within-person differences 
between time points. We calculated ICCs for total, free, and conjugated concentrations in µg/L 
and µg/g creatinine. ICCs and 95% confidence intervals were computed with natural logarithm-
transformed data using sums of squares from generalized linear models generated by the intracc 
macro for SAS (Hamer 1995). For comparison, ICCs were also computed using random effects 
models to estimate within- and between-person variance, assuming an unstructured covariance 
matrix to allow each covariance to be uniquely estimated and provide maximum model 
flexibility. The ICCs computed with random effects models produced similar results to those 
shown and thus are not presented. 
All statistical analyses were conducted using SAS software Version 9.3 (SAS Institute, Cary, 
USA). 
Results 
The majority of MoBa participants were married or co-habitating, had at least some college 
education, and a moderate income (Table 1). Although nearly half were ever-smokers, most did 
not smoke during the current pregnancy. The median age of participants at delivery was 30 years 
with a range of 20-41 years (Random Sample: median=31, range 20-41 years; High-BPA 
Subgroup: median=29, range 21-37 years). The majority of specimens (79.2%) spent 1 day in 
transit with the remainder spending 2-5 days. 
Percent detection was comparable among subgroups but varied by analyte, with most compounds 
detected in the majority of samples (Tables 2 & 3). We detected free and total concentrations in 
100% of samples for four analytes (BPA, butyl paraben, methyl paraben, propyl paraben). We 
detected total benzophenone-3 in the majority (>92%) of samples and free benzophenone-3 in 
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approximately 10%. Total concentrations of 2,4-dichlorophenol and 2,5-dichlorophenol were 
detected in fewer than 50% of samples, with negligible detection of free concentrations for these 
analytes. Ethyl paraben could not be reliably quantitated because it was a component of the urine 
preservative added to prevent bacterial growth. Additionally, two samples that did not pass the 
laboratory QA/QC criteria for free phenolic compounds concentrations were not reported. 
The geometric mean concentration of analytes for the Random Sample and High-BPA Subgroup 
were generally comparable when expressed on a µg/L basis (Table 2). When expressed on a µg/g 
creatinine basis, however, we observed a higher mean free BPA concentration at week 17 for the 
High-BPA Subgroup (Table 3). In turn, we observed a difference in mean total BPA 
concentrations between subgroups, as confirmed with a t-test comparing log-normally distributed 
means (data not shown). We also observed a higher mean conjugated methyl paraben for the 
High-BPA Subgroup, which lead to a significant difference in mean total methyl paraben 
concentrations between subgroups (data not shown). 
For all phenols and parabens, the percentage of free species in the total concentration was similar 
for the Random Sample and High-BPA Subgroup (Table 4). The majority of BPA and butyl 
paraben was in its free form. Free concentration comprised over 20% of the total biomarker 
concentration in approximately 96% of the samples analyzed for BPA and approximately 65% of 
the samples analyzed for butyl paraben (Table 4). By contrast, free propyl paraben represented 
greater than 20% of the total concentration in approximately 11% of samples, and most of the 
detected methyl paraben and benzophenone-3 was conjugated.  
For the conjugated concentrations of BPA, butyl paraben, and propyl paraben (Table 5), the 
ICCs ranged from low for BPA (~ 0.25) to moderate for butyl paraben (~ 0.40) and propyl 
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paraben (~ 0.60); this was the case regardless of subgroup or method of expressing 
concentration. For conjugated methyl paraben, the ICCs varied both by subgroup and method of 
expressing concentration, with values ranging from moderate to low, e.g., 0.34 in µg/g creatinine 
for the Random Sample and 0.06 in µg/g creatinine for the High-BPA Subgroup. 
For the free concentrations of BPA and butyl paraben, the ICCs were lower than for the 
conjugated concentrations, even approaching 0 for free BPA. This was true regardless of method 
of expressing concentration or subgroup. The ICC for free methyl paraben was approximately 
0.35 across subgroups in µg/L and approximately 0.2 in µg/g creatinine. For creatinine-adjusted 
free propyl paraben, the ICC was higher in the Random Sample (0.71) than the High-BPA 
Subgroup (0.47), while unadjusted values were more consistent across subgroups (~ 0.55). 
The ICC for the total concentrations of these phenols and parabens can be thought of as a 
weighted average of the values for the conjugated and free compounds. Thus, for BPA and butyl 
paraben, with a relatively greater proportion of free compound, the ICCs for total concentrations 
were generally low. For methyl paraben and propyl paraben, with relatively little free compound, 
the ICCs for total concentrations largely reflected the ICCs of conjugated concentrations. For 
BP-3, where a lack of detectable free concentrations prevented the computation of conjugated 
concentrations, the ICC was 0.38 in the Random Sample and 0.80 in the High-BPA Subgroup. 
ICCs computed with random effects models produced similar results (data not shown). The 
Spearman correlation coefficients among serial pairs of concentrations (conjugated, creatinine-
adjusted) were generally comparable across pairing and subgroups, consistent with the results in 
Table 5 (see Supplemental Material, Table S2). 
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Discussion  
The main purpose of our study was to examine the reliability of phenolic concentrations in a 
single spot urine sample collected during pregnancy to estimate exposure over the course of 
pregnancy in the MoBa cohort. In general, ICCs were poor to moderate, with the highest ICCs 
found consistently for propyl paraben (~ 0.60). We expect ICCs for concentrations that have 
been adjusted for creatinine to more accurately describe exposure variability, rather than 
variability in urine dilution. Results were generally similar overall and by subgroup. The small 
sample size (n=45) may also have contributed to imprecision in the estimates of average 
concentration and of the ICCs. 
Contamination likely accounts for the greater geometric mean total BPA concentrations in this 
study sample compared to other studies. When free BPA is excluded from the total analyte 
concentration, the geometric mean for conjugated BPA (1.3 µg/L) is similar to other population 
estimates for total BPA (Braun et al. 2009; Bushnik et al. 2010; CDC 2013; Hoepner et al. 2013), 
including those for pregnant women (Quiros-Alcala et al. 2013), although some previously 
reported total BPA means for pregnant women have been higher than these conjugated values 
(Meeker et al. 2013; Woodruff et al. 2011). Quantifying free BPA only provides an estimate of 
potential contamination. For butyl paraben, 88 (65%) of samples had free concentrations greater 
than 20% of total concentrations, also indicating likely contamination. There was some evidence 
of contamination with propyl paraben as well; for propyl paraben, 15 (11%) of samples had free 
concentrations greater than 20% of total, but reliability estimates were consistent for total, 
conjugated, and free concentrations. There was no evidence of contamination for methyl 
paraben, benzophenone-3, 2,4-dichlorophenol or 2,5-dichlorophenol, given either the limited 
proportion of free concentrations in the total concentration (methyl paraben, benzophenone-3) or 
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the limited detection of any free concentrations among those samples with detectable total 
concentrations (2,4-dichlorophenol, 2,5-dichlorophenol). 
In the case of MoBa, the likely sources of BPA contamination were the urinary preservative 
(sodium propionate 94%, ethyl paraben 5.6%, and chlorhexidine 0.4%) and the collection 
conditions, i.e., the hospital setting, plastic materials, and handling procedures (Longnecker et al. 
2013), despite employing procedures to limit possible contamination. Population sources of BPA 
exposure are diverse. BPA is employed in the manufacture of polycarbonate plastics (e.g., 
compact discs, plastic dinnerware, toys), epoxy resins (e.g., can linings and dental composites), 
and thermal paper (e.g., some receipts) (CDC 2009). Our results suggest that the magnitude of 
contamination varied, perhaps due to collection conditions or changes in preservative 
composition, and thus measurement of free concentrations would be required to isolate the 
possible contaminant from the conjugated fraction. Many investigators take steps to reduce 
contamination from known sources; however, contamination may also arise in unexpected ways. 
It is difficult to compare possible sources of contamination resulting from sample collection 
procedures between studies due to limited detail provided in the peer-reviewed literature. 
Although most investigators choose to measure only total phenol and paraben concentrations 
(conjugated and free combined), measuring both species in at least a subgroup of study samples 
allows for the identification of samples in which the free:total proportion is out of the expected 
range (Koch et al. 2012; Volkel et al. 2002; Waechter et al. 2007), which may indicate 
contamination. 
We also investigated whether isolating the conjugated concentrations would produce improved 
ICCs compared to those for total concentrations. Separating the conjugated from the free phenol 
did not substantially alter reliability estimates for most analytes. For both BPA and butyl 
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paraben, however, the majority of samples had a substantial proportion of these compounds 
present as free species and the conjugated analyte concentrations appeared more reliable, while 
ICCs for free concentrations were especially low. This supports four conclusions: (1) reliability 
estimates may be impacted by external sources of contamination, as indicated by higher 
concentrations than typically reported in other studies; (2) in this population, the extent of the 
specimen contamination varied, possibly due to conditions at multiple collection locations or 
variation in collection tube manufacturing (Table 2); (3) these data may also reflect daily 
variability in individual exposures that make characterization of average longer-term exposure 
challenging; and (4) the reliability of a single specimen’s concentration to categorize BPA 
exposure is rather poor, as has been reported in other studies (Braun et al. 2011a; Braun et al. 
2012; Meeker et al. 2013; Philippat et al. 2013, Jusko et al. 2014). For other phenolic 
compounds, our results were comparable to previous estimates for methyl paraben, but lower 
than prior reports for benzophenone-3, butyl paraben, and 2,4-dichlorophenol, and higher than 
prior reports for propyl paraben (Meeker et al. 2013; Philippat et al. 2013; Smith et al. 2012). 
Although the source of butyl paraben contamination in the MoBa samples could not be 
definitively established with the available information, it appears that the urinary preservative 
containing 5.6% ethyl paraben was the source of the detected ethyl paraben. The analytic 
consequences of this preservative are of primary importance to investigators analyzing affected 
specimens. Online SPE-HPLC-isotope dilution-MS/MS includes three steps: an extraction step, 
in which target analytes are preconcentrated and separated from unwanted matrix components, a 
separation step in which target compounds are separated from each other and residual matrix 
biomolecules, and a detection step in which compounds are quantified according to molecular 
mass. Generally, environmental chemicals, including phenols and parabens, are present in urine 
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at trace concentrations—at or below parts per billion. In the MoBA samples, ethyl paraben 
concentrations were in the parts per thousand range. Therefore, the detector was oversaturated, 
and the analytic performance and sensitivity of the mass spectrometer for all phenols and 
parabens measured was negatively affected, as evidenced by the QC CVs being in some cases 
twice as large as annual CVs reported by the CDC for these analytes (CDC, National Center for 
Environmental Health 2011).  
Given the extent of interference, exposure assessment for most urinary phenols and parabens 
may be difficult in the MoBa cohort using the currently available assays. It is unknown to what 
degree additional analytes might be impacted. We hypothesize that the extraction, separation, or 
quantification of compounds with physicochemical properties comparable to those of ethyl 
paraben may also be negatively impacted. Further detailed quality control studies would have to 
be conducted in order to test this hypothesis. 
Conclusions 
We demonstrated moderate reliability of a single spot urinary concentration to estimate exposure 
over an 18 week period for benzophenone-3 and propyl paraben, with lower reliability for the 
other measured analytes. Studies interested in measuring environmental chemicals should avoid, 
if at all possible, the use of preservatives that may interfere with analytic procedures and provide 
collection protocols to the analytic laboratory in advance so potential interferences can be 
anticipated. We document the utility of measuring the total and free phenol and paraben 
biomarker concentrations as a method for detecting the contamination of specimens from these 
ubiquitous compounds. 
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Table 1. Characteristics of complete study sample and subgroups.a 
Characteristic 
Complete Sample 
(n=45) 
Random Sample 
(n=30) 
High-BPA Subgroup 
(n=15) 
 
n (%) n (%) n (%) 
Civil Status    
Married 20 (44.4) 14 (46.7) 6 (40.0) 
Co-habitating 21 (46.7) 13 (43.3) 8 (53.3) 
Single 2 (  4.4) 1 (  3.3) 1 (  3.3) 
Missing 2 (  4.4) 2 (  6.7) 0 (  0.0) 
Completed Maternal Education    
< College/University 12 (26.7) 9 (30.0) 3 (20.0) 
College/University (Up to and including 4 years) 24 (53.3) 16 (53.3) 8 (53.3) 
> College/University 6 (13.3) 2 (  6.7) 4 (26.7) 
Missing 3 (  6.7) 3 (10.0) 0 (  0.0) 
Gross Income ($USD)    
< 34, 800 8 (17.8) 5 (16.7) 3 (20.0) 
34, 800 - 69, 600 27 (60.0) 18 (60.0) 9 (60.0) 
> 69, 600 7 (15.6) 4 (13.3) 3 (20.0) 
Missing 3 (  6.7) 3 (10.0) 0 (  0.0) 
Ever smoked    
No  23 (51.1) 16 (53.3) 7 (46.7) 
Yes 21 (46.7)  13 (43.3) 8 (53.3) 
Missing 1 (  2.2) 1 (  3.3) 0 (  0.0) 
Smoked during this pregnancy    
No  38 (84.4) 26 (86.7) 12 (80.0) 
Sometimes or Daily 4 (  8.8) 2 (  6.7) 2 (13.3) 
Missing 3 (  6.7) 2 (  6.7) 1 (  6.7) 
aComplete Sample (n = 45 participants, 135 samples); Random Sample = randomly selected participants with no 
previously measured BPA concentrations (n = 30 participants, 90 samples); High-BPA Subgroup = participants with 
high BPA concentrations in a previous random selection (n = 15 participants, 45 samples).
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Table 2. Limit of detection, percent detectable results, and geometric means (GM) for complete study sample and subgroups in micrograms per 
liter (µg/L).a 
 Complete Sample                         
n=45 
Random Sample                              
n=30 
High-BPA Subgroup                      
n=15 
Analyte and      
Speciesb 
n (%) 
>LOD 
GM 
all time 
periods 
GM          
17, 23, 29 weeks 
n (%) 
>LOD 
GM 
all time 
periods 
GM 
17, 23, 29 weeks 
n (%) 
>LOD 
GM 
all time 
periods 
GM 
17, 23, 29 weeks 
Bisphenol-A (LOD = 0.4 µg/L) 
Total 135 (100) 7.7 8.9, 7.5, 6.7 90 (100) 7.5 7.8, 7.4, 7.2 45 (100) 8.1 11.6, 7.8, 5.9 
Free 133 (100) 5.4 7.2, 5.2, 4.3  89 (100) 5.3 6.0, 5.6, 4.5 44 (100) 5.6 10.5, 4.6, 3.8 
Conjugated 133 (100) 1.3 1.1, 1.3, 1.6 89 (100) 1.2 1.0, 1.1, 1.4 44 (100) 1.7 1.5, 1.8, 1.9 
Butyl Paraben (LOD = 0.2 µg/L) 
Total 135 (100) 6.3 6.7, 6.1, 5.9 90 (100) 6.4 7.6, 6.0, 5.7 45 (100) 6.1 5.3, 6.4, 6.5 
Free 133 (100) 1.8 1.8, 1.8, 1.8 89 (100) 1.8 1.8, 1.8, 1.9 44 (100) 1.8 1.8, 1.9, 1.8 
Conjugated 133(100) 3.1 3.6, 3.1, 2.8 89 (100) 3.5 4.8, 3.8, 2.5 44 (100) 2.5 2.0, 2.2, 3.3 
Methyl Paraben (LOD = 1.0 µg/L) 
Total 135 (100) 1235.7 1332, 1249, 1134  90 (100) 1213.7 1297, 1256, 1097 45 (100) 1280.9 1405, 1234, 1212  
Free 133 (100) 25.7 24.1, 26.4, 26.7 89 (100) 25.7 24.7, 25.2, 27.3 44 (100) 25.7 22.9, 28.9, 25.5 
Conjugated 133 (100) 1204.5 1308, 1212, 1104 89 (100) 1181.0 1271, 1218, 1066 44 (100) 1253.5 1392, 1202, 1186 
Propyl Paraben (LOD = 0.2 µg/L) 
Total 135 (100) 32.3 29.5, 37.8, 30.2 90 (100) 36.4 40.1, 38.3, 31.4 45 (100) 25.4 16.1, 36.9, 27.8 
Free 133 (100) 1.6 1.4, 1.7, 1.6 89 (100) 1.7 1.6, 1.6, 1.7 44 (100) 1.4 1.1, 1.9, 1.3 
Conjugated 133 (100) 28.9 25.5, 35.1, 27.3 89 (100) 33.1 35.7, 36.2, 28.2 44 (100) 22.1 12.3, 33.0, 25.6 
Benzophenone-3 (LOD = 0.4 µg/L) 
Total 128 (95) 6.1 4.4, 7.0, 7.3   86 (96) 6.7 5.3, 6.5, 8.7   42 (93) 5.0 3.0, 7.9, 5.2 
Free 13 (10) NC NC 9 (10) NC NC 4 (9) NC NC 
Conjugated 13 (10) NC NC 9 (10) NC NC 4(9) NC NC 
2,4-DCP (LOD = 0.2 µg/L) 
Total 60 (44) NC NC   42 (47) NC NC   18 (40) NC NC 
Free 2 (2) NC NC 1 (1) NC NC 1 (2) NC NC 
Conjugated 2 (2) NC NC 1 (1) NC NC 1 (2) NC NC 
2,5-DCP (LOD = 0.2 µg/L) 
Total 19 (14) NC NC   11 (12) NC NC 8 (18) NC NC 
Free 0 (0) NC NC 0 (0) NC NC 0 (0) NC NC 
Conjugated 0 (0)  NC NC 0 (0) NC NC 0 (0) NC NC 
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GM = Geometric mean; µg/L = micrograms per liter; LOD = Limit of detection; NC = Not calculated due to <50% detection; 2,4-DCP = 2,4-Dichlorophenol; 
2,5-DCP = 2,5-Dichlorophenol. 
aComplete Sample (n = 45 participants, 135 samples); Random Sample = randomly selected participants with no previously measured BPA concentrations (n = 
30 participants, 90 samples); High-BPA Subgroup = participants with high BPA concentrations in a previous random selection (n = 15 participants, 45 
samples). bInstrumental readings used for total concentrations; values >LOD used for free concentrations. Conjugated concentrations, which are the difference 
between measured total and free concentrations, were calculated if both total and free were >LOD. Negative conjugated values occurred when free exceeded 
total at levels close to the LOD, which are subject to higher measurement error. Two specimens lacked reportable free phenol concentrations due to instrument 
error.
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Table 3. Limit of detection, percent detectable results, and geometric means (GM) for complete study sample and subgroups in micrograms per 
gram creatinine (µg/g creatinine).a 
 Complete Sample                               
n=45 
Random Sample                                 
n=30 
High-BPA Subgroup                               
n=15 
Analyte and 
Speciesb 
n (%) 
>LOD 
GM 
all time 
periods 
GM 
17, 23, 29 weeks 
n (%) 
>LOD 
GM 
all time 
periods 
GM 
17, 23, 29 weeks 
n (%) 
>LOD 
GM 
all time per
iods 
GM 
17, 23, 29 weeks 
Bisphenol-A (LOD = 0.4 µg/L) 
Total 135 (100) 10.9 17.9, 9.3, 7.8 90 (100) 9.6 12.3, 9.2, 7.8 45 (100) 14.1 37.8, 9.4, 7.8 
Free 133 (100) 7.7 14.3, 6.5, 5.0 89 (100) 6.9 9.5, 7.1, 4.9 44 (100) 9.6 34.1, 5.5, 5.2 
Conjugated 133 (100) 1.8 2.1, 1.6, 1.8 89 (100) 1.4 1.5, 1.3, 1.5 44 (100) 2.8 4.5, 2.2, 2.5 
Butyl Paraben (LOD = 0.2 µg/L) 
Total 135(100) 8.9 13.5, 7.5, 6.9 90 (100) 8.2 12.0, 7.5, 6.1 45 (100) 10.5 17.3, 7.6, 8.9 
Free 133 (100) 2.6 3.6, 2.3, 2.1 89 (100) 2.4 2.9, 2.3, 2.0 44 (100) 3.1 5.8, 2.2, 2.4 
Conjugated 133 (100) 4.3 6.9, 3.6, 3.3 89 (100) 4.4 7.1, 4.3, 2.7 44 (100) 4.2 6.5, 2.7, 4.5 
Methyl Paraben (LOD = 1.0 µg/L) 
Total 135 (100) 1758.9 2676, 1539, 1322 90 (100) 1563.0 2051, 1572, 1185 45 (100) 2227.5 4559, 1474, 1645 
Free 133 (100) 36.6 48.0, 33.0, 31.1 89 (100) 33.3 39.0, 32.2, 29.4 44 (100) 44.2 74.8, 34.5, 34.6 
Conjugated 133 (100) 1713.4 2604, 1512, 1286 89 (100) 1530.8 2010, 1553, 1150 44 (100) 2152.1 4536, 1435, 1609 
Propyl Paraben (LOD = 0.2 µg/L) 
Total 135 (100) 46.0 59.3, 46.6, 35.1 90 (100) 46.8 63.3, 47.9, 33.9 45 (100) 46.2 52.1, 44.0, 37.8 
Free 133 (100) 2.2 2.8, 2.1, 1.9 89 (100) 2.1 2.5, 2.1, 1.9 44 (100) 2.4 3.6, 2.2, 1.8 
Conjugated 133 (100) 41.0 50.7, 43.1, 31.8 89 (100) 42.6 56.4, 45.2, 30.4 44 (100) 38.0 40.2, 39.5, 34.8 
Benzophenone-3 (LOD = 0.4 µg/L) 
Total 128 (95) 8.5 8.8, 8.3, 8.5   86 (96) 8.5 8.4, 7.7, 9.4   42 (93) 8.6 9.6, 9.5, 7.0 
Free 13 (10) NC NC 9 (10) NC NC 4 (9) NC NC 
Conjugated 13 (10) NC NC 9 (10) NC NC 4 (9) NC NC 
2,4-DCP (LOD = 0.2 µg/L) 
Total 60 (44) NC NC   42 (47) NC NC   18 (40) NC NC 
Free 2 (2) NC NC 1 (1) NC NC 1 (2) NC NC 
Conjugated 2 (2) NC NC 1 (1) NC NC 1 (2) NC NC 
2,5-DCP (LOD = 0.2 µg/L) 
Total 19 (14) NC NC   11 (12) NC NC 8 (18) NC NC 
Free 0 (0) NC NC 0 (0) NC NC 0 (0) NC NC 
Conjugated 0 (0)  NC NC 0 (0) NC NC 0 (0) NC NC 
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GM = Geometric mean; µg/g creatinine = micrograms per gram creatinine; LOD = Limit of detection; µg/L = micrograms per liter; NC = Not calculated due to 
<50% detection; 2,4-DCP = 2,4-Dichlorophenol; 2,5-DCP = 2,5-Dichlorophenol. 
aComplete Sample (n = 45 participants, 135 samples); Random Sample = randomly selected participants with no previously measured BPA concentrations (n = 
30 participants, 90 samples); High-BPA Subgroup = participants with high BPA concentrations in a previous random selection (n = 15 participants, 45 
samples). bInstrumental readings used for total concentrations; values >LOD used for free concentrations. Conjugated concentrations, which are the difference 
between measured total and free concentrations, were calculated if both total and free were >LOD. Negative conjugated values occurred when free exceeded 
total at levels close to the LOD, which are subject to higher measurement error. Two specimens lacked reportable free phenol concentrations due to instrument 
error.
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Table 4. Comparison of free concentrations as a percent of total concentration (µg/L) for select phenols and parabens within complete study 
sample and subgroups.a 
Percentage of 
Free/Total 
Bisphenol-A                                     
n (%) 
Butyl Paraben                               
n (%) 
Methyl Paraben                           
n (%) 
Propyl Paraben                           
n (%) 
Benzophenone-3                        
n (%) 
 
Complete 
Sample 
(n=45) 
Random 
Sample 
(n=30) 
High-BPA 
Subgroup 
(n=15) 
Complete 
Sample 
(n=45) 
Random 
Sample 
(n=30) 
High-BPA 
Subgroup 
(n=15) 
Complete 
Sample 
(n=45) 
Random 
Sample 
(n=30) 
High-BPA 
Subgroup 
(n=15) 
Complete 
Sample 
(n=45) 
Random 
Sample 
(n=30) 
High-BPA 
Subgroup 
(n=15) 
Complete 
Sample 
(n=45) 
Random 
Sample 
(n=30) 
High-BPA 
Subgroup 
(n=15) 
Missing 2 (1.5) 1 (1.1) 1 (2.2) 2 (1.5) 1 (1.1) 1 (2.2) 2 (1.5) 1 (1.1) 1 (2.2) 2 (1.5) 1 (1.1) 1 (2.2) 2 (1.5) 1 (1.1) 1 (2.2) 
Free <LOD  0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 120 (88.9) 80 (88.9) 40 (88.9) 
                  0-5% 0 (0.0) 0 (0.0) 0 (0.0) 6 (4.4) 5 (5.6) 1 (2.2) 130 (96.3) 87 (96.7) 43 (95.6) 71 (52.6) 51 (56.7) 20 (44.4) 9 (6.7) 6 (6.7) 3 (6.7)
>5-10% 1 (0.7) 1 (1.1) 0 (0.0) 18 (13.3) 10 (11.1) 8 (17.8) 2 (1.5) 1 (1.1) 1 (2.2) 31 (23.0) 17 (18.9) 14 (31.1) 2 (1.5)  2 (2.2) 0 (0.0) 
>10-20% 2 (1.5) 1 (1.1) 1 (2.2) 21 (15.6) 16 (17.8) 5 (11.1) 1 (0.7) 1 (1.1) 0 (0.0) 16 (11.9) 12 (13.3) 4 (8.9) 1 (0.7) 1 (1.1) 0 (0.0) 
>20-50% 16 (11.9) 13 (14.4) 3 (6.7) 38 (28.2) 28 (31.1) 10 (22.2) 0 (0.0) 0 (0.0) 0 (0.0) 7 (5.2) 3 (3.3) 4 (8.9) 1 (0.7) 0 (0.0) 1 (2.2) 
>50% 114 (84.4) 74 (82.2) 40 (88.9) 50 (37.0) 30 (33.3) 20 (44.4) 0 (0.0) 0 (0.0) 0 (0.0) 8 (5.9) 6 (6.7) 2 (4.4) 0 (0.0) 0 (0.0) 0 (0.0) 
µg/L = micrograms per liter; LOD = Limit of detection. 
aComplete Sample (n = 45 participants, 135 samples); Random Sample = randomly selected participants with no previously measured BPA concentrations (n = 
30 participants, 90 samples); High-BPA Subgroup = participants with high BPA concentrations in a previous random selection (n = 15 participants, 45 
samples).
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Table 5. Intraclass correlation coefficients and 95% confidence intervals for total, conjugated, and free concentrations of phenols and 
parabens in micrograms per liter and micrograms per gram creatinine for complete study sample and subgroups.a 
Analyte Unadjusted concentration (µg/L) Adjusted concentration (µg/g creatinine) 
Complete Sample (n=45)  Total Conjugated Free Total Conjugated Free 
BPA 0.24 (0.09, 0.39) 0.29 (0.13, 0.44) 0.15 (0.01, 0.29) 0.04 (-0.07, 0.17) 0.24 (0.09, 0.39) 0.02 (-0.09, 0.14) 
Butyl paraben 0.34 (0.18, 0.49) 0.36 (0.20, 0.50) 0.10 (-0.04, 0.26) 0.38 (0.23, 0.53) 0.41 (0.26, 0.55) 0.12 (-0.01, 0.26) 
Methyl paraben 0.48 (0.33, 0.61) 0.47 (0.33, 0.61) 0.34 (0.18, 0.48) 0.24 (0.10, 0.40) 0.24 (0.09, 0.39) 0.24 (0.10, 0.39) 
Propyl paraben 0.55 (0.41, 0.67) 0.57 (0.44, 0.69) 0.56 (0.42, 0.68) 0.62 (0.49, 0.72) 0.64 (0.51, 0.74) 0.61 (0.47, 0.72) 
Benzophenone-3 0.43 (0.28, 0.57) NC NC 0.50 (0.35, 0.63) NC NC 
       
Random Sample (n=30)        
BPA 0.36 (0.20,0.50) 0.28 (0.13,0.43) 0.24 (0.09,0.40) 0.13 (-0.01,0.29) 0.15 (0.00, 0.31) 0.11 (-0.02,0.26) 
Butyl paraben 0.27 (0.12,0.43) 0.34 (0.19,0.49) 0.11 (-0.04,0.26) 0.30 (0.16,0.46) 0.36 (0.21, 0.51) 0.22 (0.08,0.38) 
Methyl paraben 0.53 (0.39,0.66) 0.52 (0.39,0.65) 0.34 (0.18,0.48) 0.35 (0.21,0.50) 0.34 (0.20, 0.50) 0.24 (0.10,0.40) 
Propyl paraben 0.51 (0.37,0.64) 0.53 (0.39,0.65) 0.57 (0.43,0.69) 0.58 (0.45,0.70) 0.59 (0.47, 0.71) 0.71 (0.61,0.80) 
Benzophenone-3 0.38 (0.23,0.52) NC NC   0.38 (0.23, 0.53) NC NC 
       
High-BPA Sample (n=15)        
BPAb 0.01 (-0.11,0.14) 0.22 (0.07,0.37) 0.00 (-0.10,0.13) -0.12 (-0.25, -0.12) 0.18 ( 0.05, 0.35) -0.11 (-0.23, -0.07) 
Butyl parabenb 0.50 (0.34,0.62) 0.42 (0.26,0.55) 0.11 (-0.03,0.27) 0.54 (0.44,0.69) 0.54 ( 0.42, 0.67) -0.05 (-0.16,0.05) 
Methyl paraben 0.36 (0.21,0.51) 0.35 (0.20,0.50) 0.37 (0.23,0.52) 0.06 (-0.03,0.22) 0.06 (-0.04, 0.21) 0.21 (0.10,0.39) 
Propyl paraben 0.66 (0.56,0.77) 0.67 (0.58,0.78) 0.54 (0.43,0.68) 0.73 (0.62,0.81) 0.75 ( 0.65, 0.82) 0.47 (0.35,0.63) 
Benzophenone-3 0.59 (0.50,0.74) NC NC  0.80 (0.71, 0.86) NC NC 
µg/L = micrograms per liter; µg/g creatinine = micrograms per gram of creatinine; BPA = Bisphenol-A; NC = Not calculated due to <50% 
detection. 
aComplete Sample (n = 45 participants, 135 samples); Random Sample = randomly selected participants with no previously measured BPA 
concentrations (n = 30 participants, 90 samples); High-BPA Subgroup = participants with high BPA concentrations in a previous random selection 
(n = 15 participants, 45 samples). bWhen the variance within time points exceeds the variance between subjects, a negative ICC is mathematically 
possible and can be interpreted as approximately 0 (Shrout and Fleiss 1979). 
